Bayer AG
XETRA:BAYN
Bayer AG
XETRA:BAYN
Price:
26.12 EUR
-1.28%
Updated:
Apr 16, 2024
EV/OCF
Enterprise Value to OCF
Enterprise Value to OCF
10.4
Current
14.8
Median
15.8
Industry
Lower
than median
Lower
than industry value
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
EV/OCF
=10.4
Enterprise Value
/
53.3B
Operating Cash Flow
5.1B
All Countries
| Market Cap | EV/OCF | ||||
|---|---|---|---|---|---|
| DE |
|
Bayer AG
XETRA:BAYN
|
25.8B EUR | 10.4 | |
| JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | -19 905 438.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
712.8B USD | 171.7 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
3.9T DKK | 35.3 | |
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 6 930.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
355.3B USD | 15.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
319.5B USD | 26.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
169.7B GBP | 192.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
177.5B CHF | 12 | |
| CH |
|
Novartis AG
SIX:NOVN
|
173.8B CHF | 13.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
146.3B USD | 23.4 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A
You don't have any saved screeners yet
